Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 290,962 | 277,579 | 288,263 | 285,843 | 281,652 |
| Cost of Goods | 190,394 | 184,863 | 181,943 | 183,205 | 187,361 |
| Gross Profit | 100,568 | 92,716 | 106,320 | 102,638 | 94,291 |
| Operating Expenses | 59,315 | 56,485 | 53,949 | 60,592 | 459,811 |
| Operating Income | 41,647 | 37,094 | 53,314 | 42,251 | -365,159 |
| Interest Expense | 9,967 | 11,944 | 10,659 | 10,016 | 9,526 |
| Other Income | 974 | -609 | 150 | 427 | 1,702 |
| Pre-tax Income | 32,654 | 24,541 | 42,805 | 32,662 | -372,983 |
| Income Tax | 5,576 | 5,630 | 8,649 | -2,715 | -30,554 |
| Net Income Continuous | 27,078 | 18,911 | 34,156 | 35,377 | -342,429 |
| Net Income Discontinuous | 150 | -18 | -1,732 | -3,945 | -5,549 |
| Minority Interests | 113 | 95 | 106 | 97 | -4,414 |
| Net Income | $27,115 | $18,798 | $32,318 | $31,335 | $-343,564 |
| EPS Basic Total Ops | 0.57 | 0.38 | 0.63 | 0.58 | -5.47 |
| EPS Basic Continuous Ops | 0.56 | 0.38 | 0.67 | 0.65 | -5.38 |
| EPS Basic Discontinuous Ops | -0.01 | 0.00 | -0.03 | -0.07 | -0.08 |
| EPS Diluted Total Ops | 0.57 | 0.37 | 0.63 | 0.57 | -5.46 |
| EPS Diluted Continuous Ops | 0.56 | 0.37 | 0.66 | 0.65 | -5.38 |
| EPS Diluted Discontinuous Ops | -0.01 | 0.00 | -0.03 | -0.07 | -0.08 |
| EBITDA(a) | $67,409 | $64,640 | $79,651 | $67,846 | $-32,381 |